Literature DB >> 20082065

Validity, reliability and responsiveness of a Dutch version of the prolapse quality-of-life (P-QoL) questionnaire.

Filip Claerhout1, Philip Moons, Sophie Ghesquiere, Jasper Verguts, Dirk De Ridder, Jan Deprest.   

Abstract

INTRODUCTION AND HYPOTHESIS: We aimed to test validity, reliability and responsiveness of a Dutch version of a prolapse quality-of-life questionnaire (P-QoL).
METHODS: P-QoL was translated into Dutch and adjusted by a panel of five experts. The scores of the final version were compared between symptomatic (n = 160) and asymptomatic (n = 80) patients and with findings on vaginal examination (pelvic organ prolapse quantification (POP-Q)). In terms of reliability, Cronbach's alpha was calculated, and a test-retest (n = 20) was performed. Responsiveness to treatment was assessed by comparing pre- and postoperative scores in 45 patients.
RESULTS: Total scores for each P-QoL domain were different between symptomatic and asymptomatic women (p < 0.001). Severity according to P-QoL correlated well with POP-Q findings. Cronbach's alphas showed internal consistency within the domains. Test-retest reliability was high. Pre- and postoperative scores for each domain were significantly different (p < 0.001).
CONCLUSION: The Dutch version of P-QoL is valid, reliable and responsive to assess quality-of-life and symptoms in Dutch-speaking patients with urogenital prolapse.

Entities:  

Mesh:

Year:  2010        PMID: 20082065     DOI: 10.1007/s00192-009-1081-9

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  21 in total

1.  Defining clinically meaningful change in health-related quality of life.

Authors:  Ross D Crosby; Ronette L Kolotkin; G Rhys Williams
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

2.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

3.  The relationship of vaginal prolapse severity to symptoms and quality of life.

Authors:  G Alessandro Digesu; Charlotte Chaliha; Stefano Salvatore; Anna Hutchings; Vik Khullar
Journal:  BJOG       Date:  2005-07       Impact factor: 6.531

4.  Long-term outcome of laparoscopic ventral rectopexy for total rectal prolapse.

Authors:  A D'Hoore; R Cadoni; F Penninckx
Journal:  Br J Surg       Date:  2004-11       Impact factor: 6.939

5.  A new condition-specific health-related quality of life questionnaire for the assessment of women with anal incontinence.

Authors:  G J Bug; E S Kiff; G Hosker
Journal:  BJOG       Date:  2001-10       Impact factor: 6.531

6.  Prolapse severity, symptoms and impact on quality of life among women planning sacrocolpopexy.

Authors:  M P Fitzgerald; N K Janz; P A Wren; J T Wei; A M Weber; C Ghetti; G W Cundiff
Journal:  Int J Gynaecol Obstet       Date:  2007-05-03       Impact factor: 3.561

7.  Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited.

Authors:  C Huub van der Vaart; J Rob J de Leeuw; Jan-Paul W R Roovers; A Peter M Heintz
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

8.  Validation of an Italian version of the prolapse quality of life questionnaire.

Authors:  G Alessandro Digesu; Sabino Santamato; Vik Khullar; Valeria Santillo; Antonio Digesu; Gennaro Cormio; Giuseppe Loverro; Luigi Selvaggi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-02-10       Impact factor: 2.435

9.  [Assessment of quality of life in women with pelvic organ prolapse: conditional translation and trial of P-QOL for use in Japan].

Authors:  Yumiko Fukumoto; Yuka Uesaka; Keisuke Yamamoto; Shinichiro Ito; Masaki Yamanaka; Masami Takeyama; Masanori Noma
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  2008-03

10.  Validity, reliability and responsiveness of the "Schedule for the Evaluation of Individual Quality of Life-Direct Weighting" (SEIQoL-DW) in congenital heart disease.

Authors:  Philip Moons; Kristel Marquet; Werner Budts; Sabina De Geest
Journal:  Health Qual Life Outcomes       Date:  2004-05-28       Impact factor: 3.186

View more
  6 in total

1.  Validation, reliability, and responsiveness of Prolapse Quality of Life Questionnaire (P-QOL) in a Brazilian population.

Authors:  Andrea Scarlato; Carolina Chaves Cunha Souza; Eliana Suelotto Machado Fonseca; Marair Gracio Ferreira Sartori; Manoel João Batista de Castello Girão; Rodrigo Aquino Castro
Journal:  Int Urogynecol J       Date:  2011-01-28       Impact factor: 2.894

2.  Validation of Persian version of the Prolapse Quality-of-Life questionnaire (P-QOL).

Authors:  Marzieh Nojomi; G Alessandro Digesu; Vik Khullar; Negar Morovatdar; Ladan Haghighi; Mansoureh Alirezaei; Steven Swift
Journal:  Int Urogynecol J       Date:  2011-08-17       Impact factor: 2.894

3.  Validation of the Spanish-language version of the Prolapse Quality of Life questionnaire in Chilean women.

Authors:  Claudia Flores-Espinoza; Alejandra Ximena Araya; Javier Pizarro-Berdichevsky; Vera Santos; Montserrat Ferrer; Olatz Garin; Steven Swift; Alessandro G Digesu
Journal:  Int Urogynecol J       Date:  2014-09-16       Impact factor: 2.894

Review 4.  Laparoscopic sacrocolpopexy.

Authors:  S Manodoro; E Werbrouck; J Veldman; K Haest; R Corona; F Claerhout; G Coremans; D De Ridder; F Spelzini; J Deprest
Journal:  Facts Views Vis Obgyn       Date:  2011

5.  Dysfunction, activity limitations, participation restriction and contextual factors in South African women with pelvic organ prolapse.

Authors:  Corlia Brandt; Elizabeth C Janse van Vuuren
Journal:  S Afr J Physiother       Date:  2019-02-28

Review 6.  Spanish Questionnaires for the Assessment of Pelvic Floor Dysfunctions in Women: A Systematic Review of the Structural Characteristics and Psychometric Properties.

Authors:  Marina Guallar-Bouloc; Paloma Gómez-Bueno; Manuel Gonzalez-Sanchez; Guadalupe Molina-Torres; Rafael Lomas-Vega; Alejandro Galán-Mercant
Journal:  Int J Environ Res Public Health       Date:  2021-12-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.